Xi-Yong (Sean) Fu, Phd, Mba

Xi-Yong (Sean) Fu, Phd, Mba Email and Phone Number

CEO and Board Member @ I-Mab Biopharma
Medford, MA, US
Xi-Yong (Sean) Fu, Phd, Mba's Location
Medford, Massachusetts, United States, United States
Xi-Yong (Sean) Fu, Phd, Mba's Contact Details

Xi-Yong (Sean) Fu, Phd, Mba work email

Xi-Yong (Sean) Fu, Phd, Mba personal email

n/a
About Xi-Yong (Sean) Fu, Phd, Mba

Xi-Yong (Sean) Fu, Phd, Mba is a CEO and Board Member at I-Mab Biopharma. They possess expertise in strategy, mergers and acquisitions, business development, leadership, six sigma and 30 more skills. Colleagues describe them as "Sean is an extremely intelligent and motivated person. He is equally talented in his field of expertise as he is with his people management skills. Working with and for Sean was a valuable and positive learning experience."

Xi-Yong (Sean) Fu, Phd, Mba's Current Company Details
I-Mab Biopharma

I-Mab Biopharma

View
CEO and Board Member
Medford, MA, US
Employees:
117
Xi-Yong (Sean) Fu, Phd, Mba Work Experience Details
  • I-Mab Biopharma
    Ceo And Board Member
    I-Mab Biopharma
    Medford, Ma, Us
  • I-Mab Biopharma
    Ceo & Board Member
    I-Mab Biopharma Jul 2024 - Present
    Rockville, Maryland, Us
  • Abio-X
    Operating Partner
    Abio-X Apr 2024 - Present
    Waltham, Massachusetts, Us
  • Rvac Medicines
    Co-Founder & Ceo
    Rvac Medicines Jun 2021 - Feb 2024
    RVAC is an mRNA platform company, headquartered in Singapore with R&D centers in Boston, Singapore and Shanghai.
  • Luye Pharma Group
    Group Vp And Head Of International R&D
    Luye Pharma Group Dec 2016 - Jun 2021
    Shanghai, Cn
    Led Luye International R&D organization, oversaw end-to-end R&D strategies and operations in USA, EU, & Japan. Built Luye’s first ex-China R&D center in Boston. Founding CEO of GeneLeap, a Luye incubated company focusing on nucleic acid therapies.
  • Cureport Inc
    President
    Cureport Inc Jan 2016 - Nov 2016
    Worcester, Massachusetts, Us
    Cureport is a growing U.S. pharmaceutical company committed to the development of nanomedicines leveraging its proprietary nPort™ technology for drug delivery.
  • Merck & Co
    Sr. Director, Director, Sr. Research Fellow
    Merck & Co Apr 2001 - 2016
    Various roles with increasing responsibilities covering R&D, business development, finance and operational management. Led the integration of global R&D network after the landmark $42 billion merger between Merck and Schering-PloughOperational and financial leadership for Clinical Development of Infectious and Vaccine therapeutic areas. Key filings included Elbasvir/Grazoprevir, Doravirine, Gardasil 9 and pneumococcal vaccine V116. (2012-2016)Member of Merck Capital Management Committee, overseeing $300M+ corporate capital allocation (2010-2016). Led business development deals: Cubist (2014), Oss (Netherland) Life Science Park, 2011 Newhouse (Scotland) divestiture, 2011, Insmed (US, 2009), ZINPLAVA™ (bezlotoxumab) (2009), and SmartCells (US, 2011)Key program lead and scientific contributor to the development of Isentress®, the world's first HIV integrase inhibitor. (2003-2006)

Xi-Yong (Sean) Fu, Phd, Mba Skills

Strategy Mergers And Acquisitions Business Development Leadership Six Sigma Business Planning Business Strategy Cross Functional Team Leadership Formulation Program Management Drug Development Product Development Operations Management Global Business Development R&d Project Management Capital Budgeting Team Leadership Change Management Budgets Mergers Financial Planning Business Operations Management Management Research And Development Pharmaceutical Industry Post M&a Integration Strategic Financial Planning Strategic Leadership Budgeting Pharmaceutical Development Formulation Development Budget Management Asset Divestiture Life Sciences

Xi-Yong (Sean) Fu, Phd, Mba Education Details

  • The Wharton School
    The Wharton School
    Mba
  • The Ohio State University
    The Ohio State University
    Materials Science And Engineering
  • Fudan University
    Fudan University
    Physics
  • Shanghai Jiao Tong University
    Shanghai Jiao Tong University
    Materials Science

Frequently Asked Questions about Xi-Yong (Sean) Fu, Phd, Mba

What company does Xi-Yong (Sean) Fu, Phd, Mba work for?

Xi-Yong (Sean) Fu, Phd, Mba works for I-Mab Biopharma

What is Xi-Yong (Sean) Fu, Phd, Mba's role at the current company?

Xi-Yong (Sean) Fu, Phd, Mba's current role is CEO and Board Member.

What is Xi-Yong (Sean) Fu, Phd, Mba's email address?

Xi-Yong (Sean) Fu, Phd, Mba's email address is se****@****rck.com

What schools did Xi-Yong (Sean) Fu, Phd, Mba attend?

Xi-Yong (Sean) Fu, Phd, Mba attended The Wharton School, The Ohio State University, Fudan University, Shanghai Jiao Tong University.

What skills is Xi-Yong (Sean) Fu, Phd, Mba known for?

Xi-Yong (Sean) Fu, Phd, Mba has skills like Strategy, Mergers And Acquisitions, Business Development, Leadership, Six Sigma, Business Planning, Business Strategy, Cross Functional Team Leadership, Formulation, Program Management, Drug Development, Product Development.

Who are Xi-Yong (Sean) Fu, Phd, Mba's colleagues?

Xi-Yong (Sean) Fu, Phd, Mba's colleagues are Yali Yu, Linjie C., 祝红钗, Jennifer Harrison, Huiping W., Hai W., Lihong Lou.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.